1887

Abstract

Summary

Basal defined medium (BDM) containing vitamins, minerals and seven amino acids—(/L) tryptophan 0.1 g, methionine 0.2 g, valine 0.3 g, leucine 0.3 g, proline 0.3 g, leucine 0.4 g and cysteine 0.5 g—which appeared to be essential for good growth of was prepared. Addition of glycine 0.2 g/L and threonine 0.4 g/L to BDM produced better growth of strain VPI 10463, and this defined medium was designated minimum amino acid-defined medium (MADM). Production of toxins A and B by strain VPI 10463 in 6 × MADM containing (/L) tryptophan 0.6 g, methionine 1.2 g, valine 1.8 g, leucine 1.8 g, proline 1.8 g, leucine 2.4 g, cysteine 0.5 g, glycine 0.2 g and threonine 0.4 g, was much greater than in MADM. Toxin production by 20 strains was examined in two defined media—6 × MADM and complete amino acid-defined medium (CADM) containing 18 amino acids—and one complex medium, modified brain heart infusion medium (m-BHI). Simultaneous production of toxins A and B by all test strains was demonstrated in m-BHI and the two defined media. It was also shown that 6 × MADM was generally better than CADM and as effective as m-BHI for stimulating toxin production by 13 strains. This defined medium would be useful for studies on the physiology, metabolism and pathogenicity of .

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-41-5-319
1994-11-01
2024-12-03
Loading full text...

Full text loading...

/deliver/fulltext/jmm/41/5/medmicro-41-5-319.html?itemId=/content/journal/jmm/10.1099/00222615-41-5-319&mimeType=html&fmt=ahah

References

  1. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978; 298:531–534
    [Google Scholar]
  2. George WL, Sutter VL, Goldstein EJC, Ludwig SL, Finegold SM. Aetiology of antimicrobial-agent-associated colitis. Lancet 1978; 1:802–803
    [Google Scholar]
  3. Larson HE, Price AB, Honour P, Borriello SP. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1978; 1:1063–1066
    [Google Scholar]
  4. Borriello SP, Larson HE. Antibiotic and pseudomembranous colitis. J Antimicrob Chemother 1981; 7:Suppl A53–65
    [Google Scholar]
  5. Sullivan NM, Pellett S, Wilkins TD. Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun 1982; 35:1032–1040
    [Google Scholar]
  6. Banno Y, Kobayashi T, Kono H, Watanabe K, Ueno K, Nozawa Y. Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile. Rev Infect Dis 1984; 6:Suppl 1S11–S20
    [Google Scholar]
  7. Lyerly DM, Roberts MD, Phelps CJ, Wilkins TD. Purification and properties of toxins A and B of Clostridium difficile. FEMS Microbiol Lett 1986; 33:31–35
    [Google Scholar]
  8. Lyerly DM, Krivan HC, Wilkins TD. Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1988; 1:1–18
    [Google Scholar]
  9. Rolfe RD, Finegold SM. Purification and characterization of Clostridium difficile toxin. Infect Immun 1979; 25:191–201
    [Google Scholar]
  10. Haslam SC, Ketley JM, Mitchell TJ, Stephen J, Burdon DW, Candy DCA. Growth of Clostridium difficile and production of toxins A and B in complex and defined media. J Med Microbiol 1986; 21:293–297
    [Google Scholar]
  11. Nakamura S, Nakashio S, Mikawa M, Yamakawa K, Okumura S, Nishida S. Antimicrobial susceptibility of Clostridium difficile from different sources. Microbiol Immunol 1982; 26:25–30
    [Google Scholar]
  12. Nakamura S, Mikawa M, Nakashio S. et al. Isolation of Clostridium difficile from feces and the antibody in sera of young and elderly adults. Microbiol Immunol 1981; 25:345–351
    [Google Scholar]
  13. Redmond SC, Ketley JM, Mitchell TJ, Stephen J, Burdon DW, Candy DCA. Detection of Clostridium difficile enterotoxin. Collins CH, Grange JM. (eds) Isolation and identification of micro-organisms of medical and veterinary importance Society of Applied Bacteriology, Technical Series No. 21. Academic Press; London: 1985237–250
    [Google Scholar]
  14. Smith LDS. The pathogenic anaerobic bacteria. , 2nd edn.. Springfield: Charles C. Thomas; 19753–14
    [Google Scholar]
  15. Patterson- Cirtis SI, Johnson EA. Regulation of neurotoxin and protease formation in Clostridium botulinum Okra B and Hall A by arginine. Appl Environ Microbiol 1989; 55:1544–1548
    [Google Scholar]
  16. Leyer GL, Johnson EA. Repression of toxin production by tryptophan in Clostridium botulinum type E. Arch Microbiol 1990; 154:443–447
    [Google Scholar]
  17. Lyerly DM, Sullivan NM, Wilkins TD. Enzyme-linked immunosorbent assay for Clostridium difficile toxin A. J Clin Microbiol 1983; 17:72–78
    [Google Scholar]
  18. Laughon BE, Viscidi RP, Gdovin SL, Yolken RH, Bartlett JG. Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens. J Infect Dis 1984; 149:781–788
    [Google Scholar]
  19. Wren BW, Heard SR, Tabaqchali S. Association between production of toxins A and B and types of Clostridium difficile. J Clin Pathol 1987; 40:1397–1401
    [Google Scholar]
  20. Dove CH, Wang S-Z, Price SB. et al. Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun 1990; 58:480–488
    [Google Scholar]
  21. Johnson JL, Phelps C, Barroso L, Roberts MD, Lyerly DM, Wilkins TD. Cloning and expression of the toxin B gene of Clostridium difficile. Curr Microbiol 1990; 20:397–401
    [Google Scholar]
  22. Fluit AC, Wolfhagen MJHC, Verdonk GPHT, Jansze M, Torensma R, Verhoef J. Nontoxigenic strains of Clostridium difficile lack the genes for both toxin A and toxin B. J Clin Microbiol 1991; 29:2666–2667
    [Google Scholar]
  23. McMillin DE, Muldrow LL, Leggette SJ, Abdulahi Y, Ekanemesang UM. Molecular screening of Clostridium difficile toxins A and B genetic determinants and identification of mutant strains. FEMS Microbiol Lett 1991; 78:75–80
    [Google Scholar]
  24. Borriello SP, Wren BW, Hyde S. et al. Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun 1992; 60:4192–4199
    [Google Scholar]
  25. Lyerly DM, Barroso LD, Wilkins TD, Depitre C, Corthier G. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun 1992; 60:4633–4639
    [Google Scholar]
/content/journal/jmm/10.1099/00222615-41-5-319
Loading
/content/journal/jmm/10.1099/00222615-41-5-319
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error